| 000 | 01710 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517130457.0 | ||
| 264 | 0 | _c20170607 | |
| 008 | 201706s 0 0 eng d | ||
| 022 | _a1873-2623 | ||
| 024 | 7 |
_a10.1016/j.transproceed.2016.09.021 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSuarez Benjumea, A | |
| 245 | 0 | 0 |
_aHepatitis C Virus in Kidney Transplant Recipients: A Problem on the Path to Eradication. _h[electronic resource] |
| 260 |
_bTransplantation proceedings _cNov 2016 |
||
| 300 |
_a2938-2940 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGraft Survival |
| 650 | 0 | 4 | _aHepacivirus |
| 650 | 0 | 4 |
_aHepatitis C _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppression Therapy _xmethods |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 |
_aKidney _xvirology |
| 650 | 0 | 4 | _aKidney Transplantation |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPostoperative Complications _xdrug therapy |
| 650 | 0 | 4 |
_aRibavirin _xtherapeutic use |
| 650 | 0 | 4 |
_aSofosbuvir _xtherapeutic use |
| 650 | 0 | 4 |
_aTacrolimus _xadministration & dosage |
| 700 | 1 | _aGonzalez-Corvillo, C | |
| 700 | 1 | _aSousa, J M | |
| 700 | 1 | _aBernal Blanco, G | |
| 700 | 1 | _aSuñer Poblet, M | |
| 700 | 1 | _aPerez Valdivia, M A | |
| 700 | 1 | _aGonzalez Roncero, F M | |
| 700 | 1 | _aAcevedo, P | |
| 700 | 1 | _aGentil Govantez, M A | |
| 773 | 0 |
_tTransplantation proceedings _gvol. 48 _gno. 9 _gp. 2938-2940 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.transproceed.2016.09.021 _zAvailable from publisher's website |
| 999 |
_c26678893 _d26678893 |
||